New insights and options into the mechanisms and effects of combined targeted therapy and immunotherapy in prostate cancer by Mingen Lin, Xue Sun, Lei Lv

Get full text

GABA/baclofen stabilizes PD-L1 and enhances immunotherapy of breast cancer by Xue Sun, Mingen Lin, Ziyin Tian, Yan Ma, Lei Lv

Get full text

A novel ferroptosis-related 12-gene signature predicts clinical prognosis and reveals immune relevancy in clear cell renal cell carcinoma by Yingkai Hong, Mingen Lin, Dehua Ou, Zhuangkai Huang, Peilin Shen

Get full text

Targeting fibrinogen-like protein 1 enhances immunotherapy in hepatocellular carcinoma by Mingen Lin, Jing He, Xinchao Zhang, Xue Sun, Wenjing Dong, Ruonan Zhang, Yanping Xu, Lei Lv

Get full text

FBXO38 mediates FGL1 ubiquitination and degradation to enhance cancer immunity and suppress inflammation by Tongguan Tian, Xiao Xie, Wanwan Yi, Yuefan Zhou, Yixin Xu, Zhenxiang Wang, Junjing Zhang, Mingen Lin, Ruonan Zhang, Zhongwei Lv, Xinxing Li, Lei Lv, Yanping Xu

Get full text

Publisher Correction: TET2 is required to suppress mTORC1 signaling through urea cycle with therapeutic potential by Jing He, Mingen Lin, Xinchao Zhang, Ruonan Zhang, Tongguan Tian, Yuefan Zhou, Wenjing Dong, Yajing Yang, Xue Sun, Yue Dai, Yue Xu, Zhenru Zhang, Ming Xu, Qun-Ying Lei, Yanping Xu, Lei Lv

Get full text

TET2 is required to suppress mTORC1 signaling through urea cycle with therapeutic potential by Jing He, Mingen Lin, Xinchao Zhang, Ruonan Zhang, Tongguan Tian, Yuefan Zhou, Wenjing Dong, Yajing Yang, Xue Sun, Yue Dai, Yue Xu, Zhenru Zhang, Ming Xu, Qun-Ying Lei, Yanping Xu, Lei Lv

Get full text